5-year cancer biomarker project ready to launch; Scientists find early Alzheimer's biomarker in the eye

> A five-year project which has been dubbed the most important cancer biomarker study ever conducted is set to get underway in the next few months. Story

> A team of scientists at Cedars-Sinai Medical Center in collaboration with colleagues from the Weizmann Institute of Science in Israel and the University of Southern California says that nerve cell-damaging plaque that builds up in the brain with Alzheimer's disease also builds up in the retinas of the eyes--and it shows up earlier as a key biomarker of the disease. Release

> Predictive Biomarker Sciences deployed its computer imaging tech to help direct PharmaGap's clinical strategy for a new cancer drug. PharmaGap CEO Robert McInnis says the process shaves months from its R&D schedule and hundreds of thousands of dollars in development costs. Story

> Australian scientists are adding two new biomarkers to tests for ovarian cancer. The new biomarkers should increase the accuracy of the tests from 94 percent to 97 percent. Story

> Genedata plans to demo the new Refiner MS at the 6th Metabolomics Conference 2010. The MS offers "enhanced capabilities for Mass Spectrometry-based biomarker discovery." Release

> For the first time, new biomarker tests to detect drug-induced kidney injury have been accepted by the Japanese Pharmaceuticals and Medical Devices Agency. Release

> Researchers at the Translational Genomics Research Institute (TGen), the Van Andel Research Institute and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have discovered a biomarker that could help in the treatment of patients with an aggressive type of lung cancer. Release